XELJANZ (Tofacitinib)
XELJANZ/XELJANZ XR/XELJANZ Oral Solution is a Janus kinase (JAK) inhibitor indicated for: Rheumatoid Arthritis: XELJANZ/XELJANZ XR is indicated for the treatment of adult patients…
Medication Brand Names Beginning with ‘X’, Page 4
Xeloda (Capecitabine)
XELODA is indicated as a single agent for adjuvant treatment in patients with Dukes’ C colon cancer who have undergone complete resection of the primary tumor when treatment with fluoropyrimidine therapy alone is preferred. XELODA was non-inferior…
Xeloda (Capecitabine)
XELODA (capecitabine) is a nucleoside metabolic inhibitor with antineoplastic activity indicated for: Adjuvant Colon Cancer. (1.1) — Patients with Dukes’ C colon cancer. Metastatic Colorectal Cancer. (1.1) — First-line as monotherapy when…
Xeloda (Capecitabine)
XELODA (capecitabine) is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component…
XELPROS (Latanoprost)
XELPROS (latanoprost ophthalmic emulsion) 0.005% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension…